By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Mirna Therapeutics, Inc. 

2150 Woodward Street
Suite 100
Austin  Texas  78744  U.S.A.
Phone: 512-901-0900 Fax: 512-681-5201


SEARCH JOBS








Company News
Mirna To Present At The BIO CEO & Investor And LEERINK Global Healthcare Conferences In February 2/3/2016 11:27:50 AM
Mirna To Present At The BIO CEO & Investor And LEERINK Global Healthcare Conferences In February 2/3/2016 11:19:31 AM
Mirna Appoints Peter Greenleaf To Its Board Of Directors 2/1/2016 10:30:20 AM
Rosetta Genomics Ltd. (ROSG) Grants Sublicenses To Mirna For MicroRNA-Related Patents For The Development Of Oncology Therapeutics 1/6/2016 11:21:25 AM
Mirna To Present At The Oppenheimer 26th Annual Healthcare Conference 12/2/2015 10:43:57 AM
Mirna Announces The Publication Of New Data Supporting Potential Immune-Related Mechanism For Anti-Cancer Activity Of MRX34 11/23/2015 11:23:57 AM
Mirna Reports Third Quarter Financial Results And Recent Highlights 11/13/2015 11:47:58 AM
Mirna Announces Presentation Of Interim Data From Ongoing Phase I Clinical Trial Of MRX34, First-In-Class microRNA-34 mimic, In Patients With Advanced Solid Tumors 11/9/2015 2:05:23 PM
Mirna Appoints Dr. Miguel Barbosa As Executive Vice President And Chief Scientific Officer 10/27/2015 11:11:17 AM
Mirna Announces Closing Of Initial Public Offering And Concurrent Private Placement With CPRIT 10/6/2015 12:18:45 PM
1234567
//-->